Cts Corporation · NYSE:CTS
Cts — Investor Presentation (July 2018)
25 slides from Cts's investor presentation, Jul 27, 2018
Slide 1: Investor Presentation
S Your Partner in ‘Smart Solutions Investor Presentation
Slide 2: Safe Harbor Statement
Safe Harbor Statement This presentation contains statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, any financial or other guidance, stat
Slide 3: Our Company
Our Company Ticker: CTS (NYSE) 2017 Sales: $423 Million Founded: 1896 Sales by Market: ▪ Transportation – 64% Business: CTS is a leading designer ▪ Industrial – 18% and manufacturer of sensors, ▪ Medical – 9% actuators and electronic components. ▪ Aero & Defense – 5% ▪ Telecom & IT – 4% Locations: 1
Slide 4: Our History - Years of Innovation
Our History - 120 Years of Innovation 4
Slide 5: Our Vision and Value Proposition
Our Vision and Value Proposition We aim to be a leading provider of sensing and motion devices as well as connectivity components, enabling an intelligent and seamless world. 5
Slide 6: Product Applications in Transportation
Product Applications in Transportation Engine Efficiency Occupant Safety Fuel Handling ▪ Accelerator Pedal Module ▪ Seat Belt Buckle Switch ▪ Contacting Fuel Level Card ▪ Current Sensor ▪ Seat Belt Tension Sensor ▪ Gear Position Sensor ▪ Seat Track Position Sensor ▪ Throttle Position Sensor ▪ Turbo
Slide 7: Product Applications in Industrial
Product Applications in Industrial Industrial Printers, HVAC, Automation and Safety Products ▪ Piezo Micro-Actuators ▪ Switches ▪ Encoders ▪ Frequency Control ▪ EMI Filters ▪ Flow Meter Transducers ▪ Thermal Solution For LED High Bay Lighting Industrial HVAC Industrial Inkjet Printers Key Customers
Slide 8: Product Applications in Medical
Product Applications in Medical Ultrasound / IVUS, Infusion Pumps, CPAPs and other medical devices ▪ Single Crystal Piezo ▪ Bulk Piezo ▪ Encoders ▪ Frequency Control ▪ Piezo micro-valves ▪ Switches ▪ Joysticks CPAP Machines Infusion Pumps Ultrasound Equipment Dental Equipment Wireless Pacing Key Cus
Slide 9: Product Applications in Aero & Defense
Product Applications in Aero & Defense Military Sonar and Communication Products ▪ Piezo Hydrophones ▪ Piezo Sonar Arrays ▪ Frequency Control ▪ EMI Filters Unmanned Aerial Vehicles (UAV) Maritime Applications Key Customers 9
Slide 10: Product Applications in Telecom & IT
Product Applications in Telecom & IT Communications Products ▪ RF Filters ▪ EMI/RFI Filters ▪ Frequency Control ▪ Timing Modules ▪ Thermal Products ▪ Multilayer Piezo ▪ Bulk Piezo Mobile Devices Wireline Infrastructure Small Cell Base Stations Macro Cell Base Stations Wireless Infrastructure Backhau
Slide 11: Positioning for Growth with Fundamental Market Trends
Positioning for Growth with Fundamental Market Trends Smart Home/ IndustryIndustry 4.04.0 Green Buildings Building Unmanned Autonomous Energy Aerial Vehicles Vehicle Harvesting EFFICIENT (Drones) Medical Information Industrial Technology Fuel Efficiency/ Improved Remote SMART Vehicle CONNECTED Medic
Slide 12: CTS Addressable Markets Expected to Grow Mid-Single Digits
CTS Addressable Markets Expected to Grow Mid-Single Digits Market SAM in $ Billions Organic Growth Drivers Transportation ▪ Actuators for harsh environments $3.2 ▪ RF Sensing for particulate filters ▪ Autonomous drive Industrial ▪ $1.2 3D and textile printing ▪ New products for industrial controls M
Slide 13: Organic Growth
Organic Growth Total Booked Business Investments to Grow ($ Millions) Technologies and Products that Sense, Connect and Move $1,800 $1,737 $208 $351 ▪ Improve Customer Intimacy ▪ R&D Investments at ~6% of Sales ▪ Enhance Sales Force Capabilities ▪ Improvements to Cost Structure ▪ Continuous Improvem
Slide 14: Targeted Acquisitions
Targeted Acquisitions Expand Broaden Product Geographic Range Reach Enhance Strengthen Technology Customer Portfolio Relationships Disciplined approach to acquisitions: ▪ Returns in excess of cost of capital ▪ Accretive to earnings ▪ Maintain balance sheet strength ▪ Synergy opportunities ▪ Targetin
Slide 15: The Road Ahead of Us
The Road Ahead of Us AD Targeted End Markets T&IT LV Light Vehicles 30-50% CV Industrial 20-30% Medical 10-20% O M Telecom & IT 10-20% M Commercial Vehicles 10-20% I LV/CV AD Aero & Defense 5-15% T I AD T&IT Organic Growth CV Innovation M&A M LV EMS Divestiture M AD IT/O I Front End Refocus Legend:
Slide 16: Annual Financial Performance Trend
Annual Financial Performance Trend Sales Adjusted Earnings Per Share ($ Millions) $1.55 $1.40 $465 $450 $423 $208 $1.23 Booked $397 Business $382 $1.08 $0.93 $232 Q2 YTD Actual 2015 2016 2017 2018E 2015 2016 2017 2018E Note: 2018E represents updated guidance provided on July 26, 2018. Prior guidance
Slide 17: Capital Structure
Capital Structure Cash and Debt Current Capital Structure ($ Millions) $157 Debt 14% $114 $114 $103 $91 $90 $76 $57 Equity 86% 2015 2016 2017 Q2 2018 Cash Debt Net $(66) $(24) $(38) $(46) Debt Note 1: Change in Cash/Debt in 2016 due to Single Crystal Acquisition Note 2: Total available credit increa
Slide 18: Target Capital Deployment – Disciplined Approach
Target Capital Deployment – Disciplined Approach Operating Cash Flow 12-14% of Sales Growth Return Capital to Investment Acquisitions Shareholders ~4% of Sales* 60-80% of Dividends & Buybacks Free Cash Flow 20-40% of Free Cash Flow *7-9% in 2018 Capital Structure Leverage = 1.0x - 2.5x EBITDA 18
Slide 19: Financial Framework
Financial Framework Long-Term 2012 2017 Target Range 1 Gross Margin 30.0% 34.3% 34-37% 1 SG&A Expense 20.7% 15.5% 13-15% 1 R&D Expense 6.9% 5.4% 5-7% CapEx 2.6% 4.3% ~4%* 1 Excludes the impact of the pension settlement charge recorded in Q4 2017 which reduced gross margin *7-9% in 2018 by $4.8M or 1
Slide 20: Appendix
Appendix cis
Slide 21: CTS Core Values
CTS Core Values cis 4 Play to Win © Simplicity O Responsiveness & Solution Oriented
Slide 22: Financial Summary
Financial Summary ($ Millions, except percentages and Adjusted Diluted EPS) Q2 YTD 2018 2017 2016 2015 Net Sales $231.6 $423.0 $396.7 $382.3 Adjusted Gross Margin $80.2 $145.2 $140.4 $127.1 Adjusted Gross Margin % of Sales 34.7% 34.3% 35.4% 33.2% Depreciation and Amortization $11.0 $20.7 $19.0 $16.3
Slide 23: Regulation G Schedules Adjusted Gross Margin
Regulation G Schedules Adjusted Gross Margin ($ Millions, except percentages) Q2 Year-to-Date Full Year 2018 2017 2018 2017 2017 2016 2015 Gross margin $ 41.8 $ 35.8 $ 80.2 $ 70.0 $ 140.4 $ 140.4 $ 127.1 Adjustments to reported gross margin: Pension settlement charge - - - - 4.8 - - Adjusted gross m
Slide 24: Regulation G Schedules Adjusted EBITDA
Regulation G Schedules Adjusted EBITDA ($ Millions, except percentages) Q2 Year-to-Date Full Year 2018 2017 2018 2017 2017 2016 2015 Net earnings $ 7.2 $ 10.0 $ 18.8 $ 18.5 $ 14.4 $ 34.4 $ 7.0 Depreciation and amortization expense 5.5 5.0 11.0 9.7 20.7 19.0 16.3 Interest expense 0.6 0.7 1.1 1.3 3.3
Slide 25: Regulation G Schedules Adjusted Diluted EPS
Regulation G Schedules Adjusted Diluted EPS Q2 Year-to-Date Full Year 2018 2017 2018 2017 2017 2016 2015 Diluted earnings per share $ 0.21 $ 0.30 $ 0.56 $ 0.55 $ 0.43 $ 1.03 $ 0.21 Tax affected adjustments to reported diluted earnings per share: Restructuring charges 0.03 0.01 0.06 0.03 0.08 0.06 0.